Follow
Eduardo Sabino de Camargo Magalhaes
Eduardo Sabino de Camargo Magalhaes
Verified email at umcg.nl - Homepage
Title
Cited by
Cited by
Year
Glioblastoma therapy in the age of molecular medicine
LHM Geraldo, C Garcia, ACC da Fonseca, LGF Dubois, D Matias, ...
Trends in cancer 5 (1), 46-65, 2019
832019
The multiple functions of the co-chaperone stress inducible protein 1
ACC da Fonseca, D Matias, LHM Geraldo, FS Leser, I Pagnoncelli, ...
Cytokine & growth factor reviews 57, 73-84, 2021
202021
The H3. 3K27M oncohistone affects replication stress outcome and provokes genomic instability in pediatric glioma
I Bočkaj, TEI Martini, ES de Camargo Magalhães, PL Bakker, ...
PLoS genetics 17 (11), e1009868, 2021
182021
CREB signaling activity correlates with differentiation and survival in medulloblastoma
I Armandari, WW Zomerman, SLA Plasschaert, MJ Smit, TEI Martini, ...
Scientific Reports 11 (1), 16077, 2021
52021
The developmental stage of the medulloblastoma cell-of-origin restricts Sonic hedgehog pathway usage and drug sensitivity
MJ Smit, TEI Martini, I Armandari, I Bočkaj, WW Zomerman, ...
Journal of Cell Science 135 (11), jeb258608, 2022
42022
CCL21-CCR7 signaling promotes microglia/macrophage recruitment and chemotherapy resistance in glioblastoma
LH Geraldo, C Garcia, Y Xu, FS Leser, I Grimaldi, ...
Cellular and Molecular Life Sciences 80 (7), 179, 2023
32023
DNA Damage Response− Related Proteins Are Prognostic for Outcome in Both Adult and Pediatric Acute Myelogenous Leukemia Patients: Samples from Adults and from Children Enrolled …
SE Hubner, ES de Camargo Magalhães, FW Hoff, BD Brown, Y Qiu, ...
International Journal of Molecular Sciences 24 (6), 5898, 2023
22023
Proteomics for optimizing therapy in acute myeloid leukemia: venetoclax plus hypomethylating agents versus conventional chemotherapy
ES de Camargo Magalhães, SE Hubner, BD Brown, Y Qiu, SM Kornblau
Leukemia 38 (5), 1046-1056, 2024
12024
Targeting the reprogrammed metabolism in H3. 3K27M pediatric high-grade gliomas
ES de Camargo Magalhães, ESJM de Bont, SWM Bruggeman, FRS Lima
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 167248, 2024
2024
Proteomics for Optimizing Therapy in Acute Myeloid Leukemia: Venetoclax plus Hypomethylating Agents versus Conventional Chemotherapy
S Kornblau, ES de Camargo Magalhães, S Hubner, B Brown, Q Yihua
2023
Optimizing FLT3 Inhibitor Use in Adult Acute Myeloid Leukemia with FLT3 Mutations Using Proteomics
ES Magalhaes, S Hubner, BD Brown, Y Qiu, SM Kornblau
Blood 142, 165, 2023
2023
Proteomic Profiling Identifies Unique IDH Mutant Signatures and Novel Therapeutic Opportunities in Adult Acute Myeloid Leukemia Patients
ES de Camargo Magalhaes, S Hubner, BD Brown, Y Qiu, SM Kornblau
Blood 142, 1581, 2023
2023
Genome Integrity and Reprogrammed Metabolism in H3. 3K27M High-grade Gliomas
ES de Camargo Magalhaes
2023
Proteomics-Based Strategy for the Recommendation of Conventional Chemotherapy Vs Venetoclax Plus Hypomethylating Agents in Adult Acute Myeloid Leukemia (AML)
ESC Magalhaes, BD Brown, S Hubner, Y Qiu, SM Kornblau
Blood 140 (Supplement 1), 6312-6313, 2022
2022
Epigenetic Landscape Predicts Overall Survival and Remission Duration in Adult Acute Myeloid Leukemia
ESC Magalhaes, Y Qiu, SM Kornblau
Blood 140 (Supplement 1), 6331-6332, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–15